KAPA
Kairos Pharma
$0.31
+$0.02 (+8.77%)Jul 27, 2026
Key metrics
The numbers that frame KAPA today
- Market cap
- $6.64M
- P/E (TTM)
- -1.1
- EV / FCF
- -0.8
- ROIC
- -284.4%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.27
- 52wk High
- $2.11
Growth
Revenue and earnings trend for KAPA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about KAPA
Is Kairos Pharma a good buy?
No. Kairos Pharma has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Kairos Pharma is selling at a very high price.
What is the market capitalization of KAPA?
Kairos Pharma's market capitalization is $6.64M.
What is the P/E ratio for KAPA stock?
Kairos Pharma's current P/E ratio is -1.1.
What is the 52-week high for KAPA stock?
The 52-week high for Kairos Pharma is $2.11. The current close of $0.31 is 85.3% below that high.
What is the 52-week low for KAPA stock?
The 52-week low for Kairos Pharma is $0.27. The current close of $0.31 is 14.8% above that low.
Does KAPA stock pay dividends?
Kairos Pharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for KAPA?
Kairos Pharma's Debt / Equity ratio is 0.